Departamento académico
(FM) Inmunología
Argitalpenak (28) Ikertzaileren baten partaidetza izan duten argitalpenak
2020
-
4-1BB (CD137) in anticancer chimeras
Journal of Experimental Medicine, Vol. 217, Núm. 12
-
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
Journal of Hepatology, Vol. 73, Núm. 6, pp. 1460-1469
-
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma
Blood, Vol. 135, Núm. 26, pp. 2375-2387
-
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Immunity, Vol. 52, Núm. 5, pp. 856-871.e8
-
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Drug Resistance Updates, Vol. 53
-
Cellular cytotoxicity is a form of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
-
Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence
Modern Pathology, Vol. 33, Núm. 12, pp. 2507-2519
-
Efficacy and Safety of Nivolumab plus Ipilimumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib: The CheckMate 040 Randomized Clinical Trial
JAMA Oncology
-
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Nature Medicine, Vol. 26, Núm. 5, pp. 688-692
-
Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitors
OncoImmunology, Vol. 9, Núm. 1
-
Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms
Cellular and Molecular Immunology, Vol. 17, Núm. 6, pp. 576-586
-
Exploiting TCR Recognition of Shared Hotspot Oncogene-encoded Neoantigens
Clinical Cancer Research, Vol. 26, Núm. 6, pp. 1203-1204
-
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Frontiers in Immunology, Vol. 11
-
Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death
Theranostics, Vol. 10, Núm. 10, pp. 4481-4489
-
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
Blood, Vol. 136, Núm. 2, pp. 199-209
-
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Nature Immunology, Vol. 21, Núm. 2, pp. 120-134
-
Interleukin-12 message in a bottle
Clinical Cancer Research, Vol. 26, Núm. 23, pp. 6080-6082
-
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Science Translational Medicine, Vol. 12, Núm. 565
-
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
British Journal of Haematology, Vol. 189, Núm. 6, pp. 1064-1073
-
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
ESMO open, Vol. 4, pp. e000733